Medical Xpress September 5, 2024
Rutgers University

A new study reveals that young patients treated with psychiatric medications receive potentially dangerous combinations with concerning frequency.

Researchers from Rutgers Health and other institutions recently analyzed New York State Medicaid records for more than 141,000 patients receiving any psychiatric medication. Nearly 400 of them had received at least one potentially dangerous combination for one month or longer. Doctors refer to these as severe drug-drug interactions, and their use is typically considered “contraindicated” (recommended against).

Senior study author Lawrence Kleinman, professor of pediatrics at Rutgers Robert Wood Johnson Medical School, cautioned that while some children whose illness is resistant to usual treatments may receive more benefit than the risk from the combination, “Good practice demands that patients and caregivers be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Patient / Consumer, Provider, Survey / Study, Trends
The Keys to Better Mental Healthcare in 2025? Precision, Personalization, and Progress
Embark Behavioral Health Parts with 3 C-Suite Members to Shift Resources to its Programs
How this health system builds its own behavioral health workforce
3 Ways ‘Rejection Sensitivity’ Ruins Your Mental Health—By A Psychologist
Why beds at this new behavioral health hospital are empty

Share This Article